Thread by @BullsforBears

@dr_morepen
#API Formulations HomeHealth

Api - loratadine,Atorvastatin,Montelukast,Fexofenadine,Rosuvastatin,Sitagliptin,Olmesartan,Voglibose,Dapagliflozin,Vildagliptin etc

Formulations - antibiotics,GI,CNS,Ortho,Calcium,Respiratory,Antiallergic,Nutraceuticals
#pharma #Nifty

Devices - BP monitor,Glucometer,Pulse oximeter,Thermometer

Mcap - 1320
CMP - 29.4
P/E 19.3
BV 7.36
FV 2
ROCE 10.2
OPM 8.97
D/E 0.05
EVEBIDTA 12.2
EPS 0.75
Int coverage 40.8

@dr_morepen investor presentation Q2fy21
Q2 fy20/Q2fy21 in crs
Revenue 216/340,up 57%
Ebidta 17.8/35.4,up 99%
PAT 4.08/27.17 ,up 566%
EPS 0.09/0.6,up 566%

3 verticals
Bulk drugs(#API ) - antidiabetics,antihypertensive,antivirals,anticancer,neuropsychologica
#Morepen

Diagnostic devices - glucometer, BP monitor, nebulizers,weighing scale,digital & IR thermometers, Oximeters,O2 concentrators

Finished dosages - prescription drugs mfg ,distribution, contract mfg

Manufacturing facilities
Baddi (HP) - APIs, R&D,OTC,Formulations, Diagnostic devices
Masulkhana(HP) - APIs,R&D
Parwanoo (HP) - Formulations

Revenues % Formulations 12,devices 25,API 63

Q2fy20/21 In crs
API 116/185
Diag devices 45/90
OTC 15/23
Formulations 34.7/33.4
#stocks

API growth in crs
2019 413
2020 473
1st half 21 347
Domestic 31,Exports 69
72% exports to regulated mkts - US,EU,APAC
Export revenue up 37%
Q2fy20/Q2fy21
92.4/127.56

Intellectual property - 125 patents,111 DMFs,9 China-IDLs,25 new products
#Morepen #Nifty #sensex

API expansion project under PLI scheme
Project cost 178 crs
Capacity 2000MT
New hiring 700 people
Time 3 yrs

Mkt size of #morepen products in API $4bn,go down next 5 yrs to $2.825bn,old drugs patent expired last 19 yrs
New launches addressable mkt at $35bn,expiry of patent 5yrs

Diagnostic devices
Q2fy20/21 in crs
45.52 /90.35
Glucometer contributes 71% of gross revenue in fy19-20
Q2fy21 0.408 mn glucometers & 60 million strips sold

Finished dosage rev down 4% affected by covid,recovery QoQ
Q2fy20/21 34.7/33.43

OTC
Fy20/21 15/ 23
Fy20/H121 64/44

Q2FY20/21
EPS 0.09/0.6
REV 216/340
Ebidta 17.8 /35.4
PAT 4.08 /27.17

Mar 20/ Sep 20
ROE 11.8/ 14.1%
Reserve 194/241

Unroll
@threadreaderapp
Compile
@threader_app

#Nifty #sensex #StockMarket #stocks #Markets